Cipla (CIPLA) | Stock Overview & Key Data
Cipla Performance Comparison
Stock Range
Today's Range
Low: ₹1,478.40
High: ₹1,493.50
on August 8, 2025
52 Week Range
Low: ₹1,335.00
High: ₹1,579.90
on April 7, 2025
on July 30, 2025
All-Time High: ₹1,577.00 on July 28, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR1.2T
EPS
66.74
P/E Ratio (TTM)
22.28
Forward P/E
23.40
P/B Ratio
3.85
PEG Ratio
23.40
Div. Yield
1.72%
ROE
16.85%
Beta
0.097
Debt to Equity
1.40
Financial Highlights
Profitability
Gross Margin
68.25%
Operating Margin
22.31%
Profit Margin
19.62%
Returns and Earnings
Return on Assets (TTM)
14.10%
Return on Equity (TTM)
16.85%
EBITDA
INR75.9B
Net Income (TTM)
INR53.9B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR340.26
Quarterly Revenue Growth (YoY)
3.20%
Quarterly Earnings Growth (YoY)
10.20%
Dividend Information
Last 12-Month Dividend
₹26.00
Current Dividend Yield
1.72%
3-Year Average Dividend Yield
0.76%
3-Year Average Annual Dividend
₹16.00
3-Year Total Dividends
₹48.00
Ex-Dividend Date
June 27, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Cipla CIPLA | 1.20T Large-cap | -4.09% | -1.29% | -1.18% | 1.27% | 0.78% | 3.58% | 45.16% | 93.18% |
| Sun Pharmaceutical SUNPHARMA | 3.92T Large-cap | -6.35% | -4.85% | -10.27% | -8.65% | -15.43% | -8.07% | 74.63% | 200.22% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | -7.04% | -10.99% | -0.27% | -0.15% | 0.96% | 26.95% | 64.55% | 98.44% |
| Torrent TORNTPHARM | 1.22T Large-cap | -3.88% | 7.29% | 9.29% | 10.38% | 5.21% | 5.56% | 128.85% | 24.13% |
| Mankind Pharma MANKIND | 1.08T Large-cap | -1.15% | 5.29% | 4.33% | 0.76% | -11.91% | 19.66% | 83.31% | 83.31% |
| Dr. Reddy's DRREDDY | 999.85B Large-cap | -5.47% | -8.37% | 3.45% | -3.19% | -12.29% | -14.39% | 40.91% | 32.85% |
Ownership & Short Interest
Insider Ownership
30.60%
Institutional Ownership
38.11%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
2M
Average 90-Day Volume
2M
Cipla Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Cipla would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CIPLA's 52-week high and low?
- In the last 52 weeks, Cipla reached a high of ₹1,579.90 (on July 30, 2025) and a low of ₹1,335.00 (on April 7, 2025).
- What is the market cap and P/E ratio for CIPLA?
- Curious about Cipla's size and valuation? Its market capitalization stands at 1.20T. When it comes to valuation, the P/E ratio (trailing twelve months) is 22.28, and the forward P/E (looking ahead) is 23.40.
- Does CIPLA pay dividends? If so, what's the yield?
- Yes, Cipla is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 1.72%, and the company has paid an average of ₹16.00 per share annually over the past 3 years.
- Who are Cipla's main competitors or similar companies to consider before investing?
When looking at Cipla, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.92T Healthcare Drug Manufacturers - Specialty & Generic -8.07% 74.63% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 26.95% 64.55% Torrent
TORNTPHARM1.22T Healthcare Drug Manufacturers - Specialty & Generic 5.56% 128.85% Mankind Pharma
MANKIND1.08T Healthcare Drug Manufacturers - Specialty & Generic 19.66% 83.31% Dr. Reddy's
DRREDDY999.85B Healthcare Drug Manufacturers - Specialty & Generic -14.39% 40.91% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cipla Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Cipla's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 16.85%, the Debt to Equity ratio from the most recent quarter is 1.40, and its Gross Profit Margin stands at 68.25%.
- What is the recent revenue and earnings growth for CIPLA?
- Looking at Cipla's growth, its revenue over the trailing twelve months (TTM) was INR275B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.20%, and quarterly earnings saw a YoY growth of 10.20%.
- How much of CIPLA stock is held by insiders and institutions?
- Wondering who owns Cipla stock? Company insiders (like executives and directors) hold about 30.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 38.11%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.